There are going to be many components of a pharmaceutical strategy and they don’t necessarily relate directly to the extended benefits that we provide at this time. Previously, Mr. Dolynny was talking about a catastrophic drug program for those large, expensive pharmaceutical treatments that we don’t provide support to now. Those will cover those for residents of the Northwest Territories who have incredibly high costs. We need to do the financial analysis, but many of those costs are hard to predict because many of these particular drugs or treatment programs are very rare or not used on a regular basis. But just as a note, they are not part of the Extended Health Benefits Program at this time, so it will not adversely affect that program. Thank you.